CNO Financial Group (CNO) is back in focus after its 2025 Form 10-K detailed operational performance, a planned exit from Worksite fee services by early 2026, and a three year technology modernization initiative.

At a share price of $41.81, CNO Financial Group’s recent 1 day share price return of a 2.93% decline contrasts with a 4.29% gain over 90 days and a 73.98% three year total shareholder return. This suggests longer term momentum has been stronger than the latest pullback.

If this update has you thinking about where else to put your capital to work, now could be a good time to scan our screener of 19 top founder-led companies and see what stands out.

With CNO trading at $41.81 and sitting at an estimated 40% discount to one intrinsic value estimate and 15% below an analyst target, the key question is simple: is this a genuine mispricing or is future growth already reflected in the market price?

Most Popular Narrative: 12.9% Undervalued

With CNO Financial Group at $41.81 and the most widely followed narrative pointing to a $48 fair value, the gap depends on how future earnings, margins and buybacks develop.

Analysts expect earnings to reach $432.2 million (and earnings per share of $4.91) by about September 2028, up from $288.7 million today. The analysts are largely in agreement about this estimate.

Want to see what sits behind that earnings change, margin shift and potential future P/E reset, plus the impact of a shrinking share count? The full narrative describes the assumptions used in arriving at a $48 fair value and the discount rate applied to translate those figures into a value today.

Result: Fair Value of $48 (UNDERVALUED)

However, this narrative could be tested if long term care claims trend higher again or if digital competitors pressure CNO’s margins and customer acquisition economics.

Another View: Multiples Tell A Different Story

While the SWS DCF model indicates that CNO trades at a 40.4% discount to an estimated future cash flow value of $70.19, the earnings multiple presents a more cautious picture. At a P/E of 17.2x, CNO trades above both peers at 10.9x and a fair ratio of 16x, which suggests less room for error if earnings or margins disappoint.

Next Steps

If this mix of upside and concern feels finely balanced, now may be a good time to review the numbers yourself and decide where you stand. You can start with 3 key rewards and 4 important warning signs.

Looking for more investment ideas?

If this story has sharpened your thinking on CNO, do not stop here. The real edge often comes from comparing a few quality alternatives side by side.

• Target resilient cash generators by scanning our 47 high quality undervalued stocks that pair strong fundamentals with prices that may not fully reflect their strengths yet.
• Prioritise capital preservation by reviewing 76 resilient stocks with low risk scores, focusing on companies screened for sturdier risk profiles and fewer potential surprises.
• Get ahead of the crowd by checking our screener containing 24 high quality undiscovered gems, featuring high quality names that many investors might be overlooking.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.